IRADIMED CORP (IRMD) Stock Analyst Ratings
NASDAQ:IRMD • US46266A1097
103.53 USD
+1.11 (+1.08%)
At close: Feb 27, 2026
103.53 USD
0 (0%)
After Hours: 2/27/2026, 8:11:42 PM
ChartMill assigns a Buy % Consensus number of 83% to IRMD. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 122.4. This target is 18.23% above the current price.
- IRMD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IRMD.
- In the previous month the buy percentage consensus was at a similar level.
- IRMD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-08-02 | Roth MKM | Maintains | Buy -> Buy |
| 2024-04-22 | Roth MKM | Reiterate | Buy |
| 2021-08-02 | Roth Capital | Maintains | Buy |
IRADIMED CORP / IRMD FAQ
What do analysts expect the price target to be for IRADIMED CORP (IRMD)?
8 analysts have analysed IRMD and the average price target is 122.4 USD. This implies a price increase of 18.23% is expected in the next year compared to the current price of 103.53.
How do analysts rate IRADIMED CORP (IRMD)?
The consensus rating for IRADIMED CORP (IRMD) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover IRADIMED CORP (IRMD) stock?
The number of analysts covering IRADIMED CORP (IRMD) is 8.